Insider Trading activities of Ionis Pharmaceuticals Inc (IONS)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ionis Pharmaceuticals Inc (IONS) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ionis Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Ionis Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is IONS. The reporting company's CIK number is 874015.
The total value of stock buying since 2005 is $90,940.
The total value of stock sales since 2005 is $194,534,538.
The total value of stock option exercises since 2005 is $68,733,305.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ionis Pharmaceuticals Inc (IONS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-12 0 $0 21,566 $1,399,903 21,566 $340,814
2019-11 0 $0 16,588 $1,002,891 8,000 $86,560
2019-10 0 $0 0 $0 3,556 $0
2019-08 0 $0 22,000 $1,573,500 22,000 $877,139
2019-07 0 $0 10,210 $716,454 25,987 $398,700
2019-06 0 $0 30,000 $1,933,425 30,000 $489,600
2019-05 0 $0 8,000 $582,000 8,000 $195,360
2019-04 0 $0 177,768 $14,489,496 174,768 $6,875,263
2019-03 0 $0 47,134 $3,690,490 37,134 $2,105,492
2019-02 0 $0 188,924 $11,646,319 187,925 $6,944,913
2019-01 0 $0 4,614 $252,569 99,616 $111,518
2018-12 0 $0 4,063 $211,379 4,063 $29,456
2018-11 0 $0 46,500 $2,489,318 46,500 $683,085
2018-08 0 $0 28,993 $1,453,122 28,993 $256,369
2018-07 0 $0 156 $7,336 43,335 $277,800
2018-06 0 $0 15,000 $633,750 15,000 $208,200
2018-05 0 $0 42,500 $1,933,455 42,500 $507,025
2018-04 0 $0 13,962 $619,912 13,962 $178,085
2018-03 0 $0 5,000 $250,066 5,000 $108,500
2018-02 0 $0 6,000 $301,905 6,000 $213,180
2018-01 0 $0 75,555 $3,878,249 125,815 $497,954
2017-12 0 $0 16,000 $853,000 16,000 $274,249
2017-11 0 $0 22,250 $1,204,250 22,062 $330,443
2017-10 0 $0 81,636 $4,830,565 80,829 $1,122,898
2017-09 0 $0 1,000 $55,000 1,000 $7,250
2017-07 0 $0 54,309 $2,943,682 69,283 $565,119
2017-06 0 $0 70 $3,360 70 $757
2017-05 0 $0 13,150 $596,937 13,000 $127,535
2017-04 0 $0 45,500 $1,984,379 44,500 $352,273
2017-03 0 $0 23,225 $1,194,467 22,225 $230,917
2017-02 0 $0 1,500 $69,502 13,937 $126,642
2017-01 0 $0 68,656 $3,266,572 111,652 $279,763
2016-12 0 $0 19,480 $866,822 19,350 $244,587
2016-11 0 $0 69,305 $2,616,999 69,305 $718,181
2016-10 0 $0 11,000 $402,710 11,000 $113,189
2016-09 0 $0 56,500 $1,947,931 56,500 $589,883
2016-07 0 $0 0 $0 12,534 $0
2016-05 0 $0 12,500 $278,900 12,500 $74,125
2016-04 0 $0 12,000 $552,375 12,000 $124,009
2016-03 0 $0 12,000 $493,485 12,000 $121,062
2016-02 0 $0 0 $0 13,438 $74,125
2016-01 0 $0 48,151 $2,363,315 84,145 $181,876
2015-12 0 $0 8,909 $515,544 8,909 $121,693
2015-11 0 $0 17,875 $1,093,187 17,875 $228,400
2015-10 0 $0 56,436 $2,440,275 56,436 $607,924
2015-07 0 $0 24,984 $1,430,987 33,319 $245,038
2015-06 0 $0 17,600 $1,172,389 17,600 $117,704
2015-04 0 $0 54,942 $3,434,492 64,942 $651,016
2015-03 0 $0 154,514 $11,140,929 147,499 $1,822,552
2015-02 0 $0 10,000 $621,460 10,938 $39,500
2015-01 0 $0 77,697 $5,304,967 100,697 $628,856
2014-12 0 $0 1,500 $76,815 1,500 $10,875
2014-11 0 $0 1,500 $69,255 1,500 $10,875
2014-10 0 $0 63,171 $2,559,956 63,171 $726,171
2014-09 0 $0 12,571 $506,183 12,571 $112,526
2014-08 0 $0 66,944 $2,392,807 66,944 $780,915
2014-07 0 $0 19,243 $683,664 23,535 $249,986
2014-06 0 $0 44,700 $1,504,547 44,700 $561,078
2014-04 0 $0 10,300 $450,702 20,300 $196,536
2014-03 0 $0 1,500 $74,550 1,500 $16,455
2014-02 0 $0 6,200 $304,956 11,500 $74,105
2014-01 0 $0 200,161 $9,331,794 204,046 $1,972,297
2013-12 0 $0 137,542 $5,630,883 132,811 $1,693,629
2013-11 0 $0 16,000 $587,494 0 $0
2013-09 0 $0 379,641 $12,660,157 327,656 $4,548,129
2013-08 0 $0 21,659 $603,584 18,750 $216,937
2013-07 0 $0 412,827 $12,461,933 351,978 $4,752,494
2013-06 0 $0 192,554 $5,095,517 157,107 $1,529,655
2013-05 0 $0 39,945 $886,205 39,945 $320,156
2013-04 0 $0 380,249 $8,147,219 330,249 $3,442,004
2013-03 0 $0 158,453 $2,814,983 158,453 $1,516,129
2013-02 0 $0 8,189 $117,269 18,050 $118,277
2013-01 0 $0 7,859 $105,503 10,302 $20,580
2012-12 0 $0 6,000 $57,750 6,000 $31,500
2012-09 0 $0 288,073 $4,253,922 288,073 $1,630,541
2012-07 0 $0 35,207 $474,811 32,186 $182,053
2012-06 0 $0 21,579 $243,197 30,000 $244,500
2012-05 0 $0 20,000 $190,817 20,000 $187,999
2011-12 0 $0 123,462 $847,269 123,462 $1,446,137
2011-08 0 $0 10,000 $76,210 10,000 $52,500
2011-07 0 $0 1,000 $8,600 0 $0
2010-12 0 $0 104,330 $1,088,291 113,030 $1,091,800
2010-07 0 $0 1,100 $10,560 0 $0
2010-06 0 $0 10,000 $98,948 10,000 $58,000
2009-12 0 $0 407,535 $4,210,532 417,535 $2,843,866
2009-07 0 $0 17,133 $285,701 12,000 $81,720
2009-04 0 $0 20,000 $305,230 20,000 $136,200
2009-01 0 $0 3,364 $47,561 0 $0
2008-12 0 $0 74,973 $1,008,152 74,973 $875,132
2008-09 0 $0 10,000 $181,119 10,000 $68,100
2008-08 0 $0 84,000 $1,545,760 74,000 $559,015
2008-07 0 $0 5,338 $74,375 0 $0
2008-06 0 $0 0 $0 4,000 $53,000
2008-04 0 $0 27,500 $434,302 27,500 $165,856
2008-01 0 $0 2,406 $46,387 0 $0
2007-12 0 $0 70,000 $1,166,425 72,100 $887,695
2007-11 0 $0 79,851 $1,438,703 79,851 $444,472
2007-10 0 $0 20,000 $304,660 20,000 $246,240
2007-09 0 $0 105,466 $1,521,773 105,466 $888,267
2007-08 0 $0 10,000 $125,000 10,000 $62,500
2007-07 0 $0 32,669 $370,411 29,799 $164,414
2007-05 0 $0 4,800 $49,519 4,800 $24,720
2007-04 0 $0 19,711 $199,278 16,000 $77,450
2006-12 0 $0 16,100 $191,084 16,100 $109,641
2006-11 0 $0 220,688 $2,603,188 160,688 $933,617
2006-10 0 $0 22,424 $191,297 22,424 $119,521
2006-08 4,000 $24,520 0 $0 0 $0
2006-07 4,000 $23,860 0 $0 0 $0
2006-05 0 $0 8,500 $72,658 8,500 $49,300
2006-03 0 $0 52,166 $455,996 52,166 $311,451
2006-02 2,000 $10,960 62,059 $496,588 60,559 $329,710
2006-01 4,000 $21,240 0 $0 0 $0
2005-12 2,000 $10,360 0 $0 0 $0
2005-09 0 $0 5,708 $30,662 0 $0
2005-06 0 $0 4,446 $17,806 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Ionis Pharmaceuticals Inc insiders (IONS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-12-09 Klein Joseph Iii (Director) Sale 1,000 63.74 63,745
2019-12-09 Klein Joseph Iii (Director) Option Ex 1,000 35.53 35,530
2019-12-04 Geary Richard S (SVP, Development) Sale 10,000 65.00 650,000
2019-12-04 Geary Richard S (SVP, Development) Option Ex 10,000 14.69 146,900
2019-12-04 Hougen Elizabeth L (SVP, Finance & CFO) Sale 4,566 65.00 296,790
2019-12-04 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 4,566 10.82 49,404
2019-12-02 Geary Richard S (SVP, Development) Sale 5,000 65.06 325,285
2019-12-02 Geary Richard S (SVP, Development) Option Ex 5,000 14.69 73,450
2019-12-02 Klein Joseph Iii (Director) Sale 1,000 64.08 64,083
2019-12-02 Klein Joseph Iii (Director) Option Ex 1,000 35.53 35,530
2019-11-25 Klein Joseph Iii (Director) Sale 812 62.90 51,074
2019-11-25 Hougen Elizabeth L (SVP, Finance & CFO) Sale 4,000 62.50 250,000
2019-11-25 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 4,000 10.82 43,280
2019-11-20 Monia Brett P (COO & SVP, Translational Med) Sale 5,776 60.01 346,617
2019-11-20 Klein Joseph Iii (Director) Sale 2,000 60.00 120,000
2019-11-19 Hougen Elizabeth L (SVP, Finance & CFO) Sale 4,000 58.80 235,200
2019-11-19 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 4,000 10.82 43,280
2019-10-15 Reikes Peter N (Director) Option Ex 1,778 .00 0
2019-10-15 Hayden Michael R (Director) Option Ex 1,778 .00 0
2019-08-21 Crooke Stanley T (Chairman and CEO) Sale 10,000 72.15 721,500
2019-08-21 Crooke Stanley T (Chairman and CEO) Option Ex 10,000 39.87 398,700
2019-08-20 Crooke Stanley T (Chairman and CEO) Sale 12,000 71.00 852,000
2019-08-20 Crooke Stanley T (Chairman and CEO) Option Ex 12,000 39.87 478,439
2019-07-18 Crooke Stanley T (Chairman & CEO) Sale 10,000 70.25 702,510
2019-07-18 Crooke Stanley T (Chairman & CEO) Option Ex 10,000 39.87 398,700
2019-07-15 Mcdevitt Damien (Chief Business Officer) Option Ex 3,542 .00 0
2019-07-03 Loscalzo Joseph (Director) Option Ex 667 .00 0
2019-07-03 Klein Joseph Iii (Director) Option Ex 667 .00 0
2019-07-03 Muto Frederick T (Director) Option Ex 667 .00 0
2019-07-03 Wender Joseph H (Director) Option Ex 667 .00 0
2019-07-02 Monia Brett P (Chief Operating Officer) Sale 210 66.40 13,944
2019-07-02 Loscalzo Joseph (Director) Option Ex 889 .00 0
2019-07-02 Klein Joseph Iii (Director) Option Ex 889 .00 0
2019-07-02 Muto Frederick T (Director) Option Ex 889 .00 0
2019-07-02 Parshall B Lynne (Director) Option Ex 889 .00 0
2019-07-02 Wender Joseph H (Director) Option Ex 889 .00 0
2019-07-01 Loscalzo Joseph (Director) Option Ex 1,333 .00 0
2019-07-01 Klein Joseph Iii (Director) Option Ex 1,333 .00 0
2019-07-01 Muto Frederick T (Director) Option Ex 1,333 .00 0
2019-07-01 Wender Joseph H (Director) Option Ex 1,333 .00 0
2019-06-24 Berthelsen Spencer R (Director) Sale 15,000 63.60 954,075
2019-06-24 Berthelsen Spencer R (Director) Option Ex 15,000 16.32 244,800
2019-06-04 Muto Frederick T (Director) Sale 15,000 65.29 979,350
2019-06-04 Muto Frederick T (Director) Option Ex 15,000 16.32 244,800
2019-05-06 Muto Frederick T (Director) Sale 8,000 72.75 582,000
2019-05-06 Muto Frederick T (Director) Option Ex 8,000 24.42 195,360
2019-04-29 Parshall B Lynne (Director) Sale 50,000 75.01 3,750,650
2019-04-29 Parshall B Lynne (Director) Option Ex 50,000 39.87 1,993,499
2019-04-16 Crooke Stanley T (Chairman and CEO) Sale 21,000 84.70 1,778,763
2019-04-16 Crooke Stanley T (Chairman and CEO) Option Ex 21,000 26.31 552,573
2019-04-15 Crooke Stanley T (Chairman and CEO) Sale 11,000 85.25 937,750
2019-04-15 Crooke Stanley T (Chairman and CEO) Option Ex 11,000 12.76 140,305
2019-04-08 Geary Richard S (SVP, Development) Sale 46,240 84.01 3,884,529
2019-04-08 Geary Richard S (SVP, Development) Option Ex 46,240 33.97 1,570,634
2019-04-05 O'neil Patrick R. (SVP Legal & General Counsel) Sale 2,252 84.75 190,857
2019-04-05 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 2,252 61.68 138,903
2019-04-04 O'neil Patrick R. (SVP Legal & General Counsel) Sale 39,622 83.23 3,297,659
2019-04-04 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 36,622 54.81 2,007,251
2019-04-03 O'neil Patrick R. (SVP Legal & General Counsel) Sale 7,654 84.83 649,288
2019-04-03 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 7,654 61.68 472,098
2019-03-19 Wender Joseph H (Director) Sale 10,000 79.63 796,260
2019-03-18 O'neil Patrick R. (SVP Legal & General Counsel) Sale 28,800 78.79 2,269,180
2019-03-18 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 28,800 61.57 1,773,216
2019-03-12 Parshall B Lynne (Director) Sale 8,334 75.00 625,050
2019-03-12 Parshall B Lynne (Director) Option Ex 8,334 39.87 332,276
2019-02-27 O'neil Patrick R. (SVP Legal & General Counsel) Sale 26,800 67.34 1,804,631
2019-02-27 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 26,800 44.85 1,201,980
2019-02-27 Parshall B Lynne (Director) Sale 8,333 70.00 583,310
2019-02-27 Parshall B Lynne (Director) Option Ex 8,333 39.87 332,236
2019-02-26 Crooke Stanley T (Chairman and CEO) Sale 37,000 61.53 2,276,795
2019-02-26 Crooke Stanley T (Chairman and CEO) Option Ex 37,000 39.87 1,475,190
2019-02-25 Crooke Stanley T (Chairman and CEO) Sale 40,000 60.07 2,402,720
2019-02-25 Crooke Stanley T (Chairman and CEO) Option Ex 40,000 39.87 1,594,800
2019-02-13 Geary Richard S (SVP, Development) Sale 999 60.00 59,940
2019-02-13 Crooke Stanley T (Chairman and CEO) Sale 46,904 60.03 2,815,834
2019-02-13 Crooke Stanley T (Chairman and CEO) Option Ex 46,904 30.19 1,415,891
2019-02-12 O'neil Patrick R. (SVP Legal & General Counsel) Sale 275 59.50 16,362
2019-02-12 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 275 39.87 10,964
2019-02-05 O'neil Patrick R. (SVP Legal & General Counsel) Sale 15,600 59.50 928,200
2019-02-05 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 15,600 39.87 621,972
2019-02-01 O'neil Patrick R. (SVP Legal & General Counsel) Sale 4,000 58.29 233,160
2019-02-01 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 4,000 39.87 159,480
2019-02-01 Bennett C Frank (SVP, Antisense Research) Sale 9,013 58.29 525,367
2019-02-01 Bennett C Frank (SVP, Antisense Research) Option Ex 9,013 14.69 132,400
2019-01-15 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 7,823 .00 0
2019-01-15 Monia Brett P (Chief Operating Officer) Option Ex 10,006 .00 0
2019-01-15 Geary Richard S (SVP, Development) Option Ex 8,085 .00 0
2019-01-15 Hougen Elizabeth L (SVP Finance & CFO) Option Ex 7,891 .00 0
2019-01-15 Bennett C Frank (SVP, Antisense Research) Option Ex 7,822 .00 0
2019-01-15 Parshall B Lynne (Director) Option Ex 20,656 .00 0
2019-01-15 Crooke Stanley T (Chairman and CEO) Option Ex 32,933 .00 0
2019-01-03 O'neil Patrick R. (SVP Legal & General Counsel) Sale 4,400 54.80 241,120
2019-01-03 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 4,400 25.34 111,518
2019-01-02 Monia Brett P (Chief Operating Officer) Sale 214 53.50 11,449
2018-12-19 Hougen Elizabeth L (SVP, Finance & CFO) Sale 2,063 52.05 107,379
2018-12-19 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 2,063 7.25 14,956
2018-12-18 Hougen Elizabeth L (SVP, Finance & CFO) Sale 2,000 52.00 104,000
2018-12-18 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 2,000 7.25 14,500
2018-11-23 Monia Brett P (Chief Operating Officer) Sale 34,000 55.00 1,870,068
2018-11-23 Monia Brett P (Chief Operating Officer) Option Ex 34,000 14.69 499,460
2018-11-01 Bennett C Frank (SVP, Antisense Research) Sale 12,500 49.54 619,250
2018-11-01 Bennett C Frank (SVP, Antisense Research) Option Ex 12,500 14.69 183,625
2018-08-27 Monia Brett P (Chief Operating Officer) Sale 16,493 54.00 890,622
2018-08-27 Monia Brett P (Chief Operating Officer) Option Ex 16,493 7.23 119,244
2018-08-08 Bennett C Frank (SVP, Antisense Research) Sale 12,500 45.00 562,500
2018-08-08 Bennett C Frank (SVP, Antisense Research) Option Ex 12,500 10.97 137,125
2018-07-24 Monia Brett P (Chief Operating Officer) Sale 156 47.03 7,336
2018-07-17 Wender Joseph H (Director) Option Ex 30,000 9.26 277,800
2018-07-03 Castleman Breaux (Director) Option Ex 667 .00 0
2018-07-03 Loscalzo Joseph (Director) Option Ex 667 .00 0
2018-07-03 Klein Joseph Iii (Director) Option Ex 667 .00 0
2018-07-03 Berthelsen Spencer R (Director) Option Ex 667 .00 0
2018-07-03 Wender Joseph H (Director) Option Ex 667 .00 0
2018-07-01 Castleman Breaux (Director) Option Ex 2,000 .00 0
2018-07-01 Loscalzo Joseph (Director) Option Ex 2,000 .00 0
2018-07-01 Klein Joseph Iii (Director) Option Ex 2,000 .00 0
2018-07-01 Berthelsen Spencer R (Director) Option Ex 2,000 .00 0
2018-07-01 Wender Joseph H (Director) Option Ex 2,000 .00 0
2018-06-25 Berthelsen Spencer R (Director) Sale 15,000 42.25 633,750
2018-06-25 Berthelsen Spencer R (Director) Option Ex 15,000 13.88 208,200
2018-05-31 Muto Frederick T (Director) Sale 15,000 46.45 696,750
2018-05-31 Muto Frederick T (Director) Option Ex 15,000 13.88 208,200
2018-05-11 Bennett C Frank (SVP, Antisense Research) Sale 12,500 45.00 562,500
2018-05-11 Bennett C Frank (SVP, Antisense Research) Option Ex 12,500 7.25 90,625
2018-05-11 Wender Joseph H (Director) Sale 15,000 44.95 674,205
2018-05-11 Wender Joseph H (Director) Option Ex 15,000 13.88 208,200
2018-04-17 Crooke Stanley T (Chairman and CEO) Sale 13,962 44.40 619,912
2018-04-17 Crooke Stanley T (Chairman and CEO) Option Ex 13,962 12.76 178,085
2018-03-29 Klein Joseph Iii (Director) Sale 2,000 46.15 92,300
2018-03-29 Klein Joseph Iii (Director) Option Ex 2,000 24.42 48,840
2018-03-15 Klein Joseph Iii (Director) Sale 2,000 51.38 102,766
2018-03-15 Klein Joseph Iii (Director) Option Ex 2,000 24.42 48,840
2018-03-12 O'neil Patrick R. (SVP Legal & General Counsel) Sale 1,000 55.00 55,000
2018-03-12 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 1,000 10.82 10,820
2018-02-28 Klein Joseph Iii (Director) Sale 3,000 51.66 154,965
2018-02-28 Klein Joseph Iii (Director) Option Ex 3,000 35.53 106,590
2018-02-15 Klein Joseph Iii (Director) Sale 3,000 48.98 146,940
2018-02-15 Klein Joseph Iii (Director) Option Ex 3,000 35.53 106,590
2018-01-29 O'neil Patrick R. (SVP Legal & General Counsel) Sale 355 55.00 19,525
2018-01-29 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 355 10.82 3,841
2018-01-25 O'neil Patrick R. (SVP Legal & General Counsel) Sale 645 55.00 35,475
2018-01-25 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 645 10.82 6,978
2018-01-16 Boyce Sarah (Chief Business Officer) Sale 2,196 51.76 113,664
2018-01-16 O'neil Patrick R. (SVP, Legal & General Counsel) Sale 2,697 51.76 139,596
2018-01-16 Monia Brett P (COO) Sale 2,821 51.76 146,014
2018-01-16 Geary Richard S (SVP, Development) Sale 2,723 51.76 140,942
2018-01-16 Klein Joseph Iii (Director) Sale 3,000 52.55 157,650
2018-01-16 Klein Joseph Iii (Director) Option Ex 3,000 35.53 106,590
2018-01-16 Hougen Elizabeth L (SVP, Finance & CFO) Sale 2,724 51.76 140,994
2018-01-16 Bennett C Frank (SVP, Antisense Research) Sale 2,696 51.76 139,544

Insider trading activities including stock purchases, stock sales, and option exercises of IONS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ionis Pharmaceuticals Inc (symbol IONS, CIK number 874015) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month